녹십자

006280KOSPI

51.5 / 100

Reference Date: 2026-10-23

Financial Score20.0 / 40

News Sentiment12.5 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 5.5% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

LG Chem is a pharmaceutical company specializing in blood products and vaccines, with 2025 consolidated sales reaching 19.9 trillion won, a 18.54% increase from the previous year. Key products include ALYGLO, successfully launched in the U.S. market, the WHO-certified chickenpox vaccine 'BariCella', and the hemophilia treatment 'Greenjin E' approved in China. The company is focused on global expansion through strategic products and innovation.

Number of Employees

2,351people

Average Salary

73.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

1.09Industry Average 1.204.0Point

In line with industry avg

ROE

-2.07Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

30.91Industry Average 100.006.5Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲10.9% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲54.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -2.1% (declining, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (24%)

Current 129,700Won52-week high 180,30052-week low 113,200

1-month return4.0Point

1m +5.53% (slight rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0